NCT06325930View on ClinicalTrials.gov

A Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-HU6

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 26, 2024

Primary Completion Date

May 7, 2024

Study Completion Date

May 7, 2024

Conditions
Healthy
Interventions
DRUG

[14C]-HU6

\[14C\]-HU6 following a single dose of HU6 in healthy, adult male subjects

Trial Locations (1)

21201

Pharmaron Clinical Pharmacology Center (CPC), Baltimore

All Listed Sponsors
lead

Rivus Pharmaceuticals, Inc.

INDUSTRY

NCT06325930 - A Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-HU6 | Biotech Hunter | Biotech Hunter